BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres Hernandez AX, Weeramange CJ, Desman P, Fatino A, Haney O, Rafferty RJ. Efforts in redesigning the antileukemic drug 6-thiopurine: decreasing toxic side effects while maintaining efficacy. Medchemcomm 2019;10:169-79. [PMID: 30774864 DOI: 10.1039/c8md00463c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Darbandi A, Gavahi M, Shirani Bidabadi E, Kadhim MM, Naghsh N, Canli G, Ahmed OS. Complexation of mercaptopurine anticancer drug with an iron-doped fullerene cage: DFT assessments of drug delivery approach. Physics Letters A 2022;448:128318. [DOI: 10.1016/j.physleta.2022.128318] [Reference Citation Analysis]
2 Dallman J, Lansakara A, Nguyen T, Weeramange C, Hulangamuwa W, Rafferty RJ. The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery. Medchemcomm 2019;10:1420-31. [PMID: 31673309 DOI: 10.1039/c9md00052f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Weeramange C, Lansakara A, Dallman J, Nguyen T, Hulangamuwa W, Rafferty RJ. New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators. Medchemcomm 2019;10:717-25. [PMID: 31191862 DOI: 10.1039/c9md00010k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]